Feature article: Recognising the value of Intellectual Property
IP rights – always intangible, often inscrutable, but never inconsequential
Intellectual Property (IP) rights protect innovation and allow companies to commercialise their endeavours. While this sounds straightforward, the challenge in raising capital to fund development has risen significantly recently as the world has responded to macro challenges and investors have become more risk averse. This has called into question the ability of some companies to continue to fund their innovation projects. Essentially, these businesses are “innovation-rich but cash-poor”.
In these circumstances what could happen to their IP? Is it vulnerable? Could it be lost? Can it be sold? Could shareholders lose out? Most importantly, what is IP worth?
Investors are beginning to ask questions, highlighting their desire to understand IP better – particularly as it relates to knowledge-intensive businesses. We begin here by addressing some of these issues.
02 May 2023
Hardman & Co Monthly: May 2023
Volta Finance Limited (VTA:LON), 504 | Tissue Regenix Group plc (TRX:LON), 61.5 | Real Estate Credit Investments Limited (RECI:LON), 116 | Pantheon International Plc (PIN:LON), 323 | ICG Enterprise Trust PLC GBP (ICGT:LON), 1,198 | International Biotechnology Trust PLC (IBT:LON), 610 | H&T Group plc (HAT:LON), 406 | Advanced Oncotherapy Plc (AVO:LON), 1.9 | Apax Global Alpha Ltd. (APAX:LON), 140 | Arbuthnot Banking Group PLC (ARBB:LON), 1,075 | Chesnara Plc (CSN:LON), 259
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Hardman & Co Monthly: May 2023
Volta Finance Limited (VTA:LON), 504 | Tissue Regenix Group plc (TRX:LON), 61.5 | Real Estate Credit Investments Limited (RECI:LON), 116 | Pantheon International Plc (PIN:LON), 323 | ICG Enterprise Trust PLC GBP (ICGT:LON), 1,198 | International Biotechnology Trust PLC (IBT:LON), 610 | H&T Group plc (HAT:LON), 406 | Advanced Oncotherapy Plc (AVO:LON), 1.9 | Apax Global Alpha Ltd. (APAX:LON), 140 | Arbuthnot Banking Group PLC (ARBB:LON), 1,075 | Chesnara Plc (CSN:LON), 259
- Published:
02 May 2023 -
Author:
Brian Moretta | Martin Hall | Mike Foster | Mark Thomas -
Pages:
20
Feature article: Recognising the value of Intellectual Property
IP rights – always intangible, often inscrutable, but never inconsequential
Intellectual Property (IP) rights protect innovation and allow companies to commercialise their endeavours. While this sounds straightforward, the challenge in raising capital to fund development has risen significantly recently as the world has responded to macro challenges and investors have become more risk averse. This has called into question the ability of some companies to continue to fund their innovation projects. Essentially, these businesses are “innovation-rich but cash-poor”.
In these circumstances what could happen to their IP? Is it vulnerable? Could it be lost? Can it be sold? Could shareholders lose out? Most importantly, what is IP worth?
Investors are beginning to ask questions, highlighting their desire to understand IP better – particularly as it relates to knowledge-intensive businesses. We begin here by addressing some of these issues.